35.51

5.59% 1.845

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $35.51, with a volume of 609.01K. It is up +5.59% in the last 24 hours and up +28.63% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Previous Close:

$33.66

Open:

$33.33

24h Volume:

609.01K

Relative Volume:

1.03

Market Cap:

$1.72B

Revenue:

$429.95M

Net Income/Loss:

$-40.12M

P/E Ratio:

-65.75

EPS:

-0.54

Net Cash Flow:

$-19.66M

1W Performance:

+20.76%

1M Performance:

+28.63%

6M Performance:

+70.13%

1Y Performance:

-3.89%

1-Day Range:

$33.30

$35.69

1-Week Range:

$33.08

$36.61

52-Week Range:

$18.94

$43.00

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1181)

Industry

Medical Instruments & Supplies (58)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,200

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

Nov 03, 2024

Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Nov 03, 2024

Nov 02, 2024

Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday - MSN

Nov 02, 2024

Nov 01, 2024

US$42.67That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results - Simply Wall St

Nov 01, 2024

Oct 31, 2024

Earnings call: AtriCure reports robust growth, raises full-year guidance By Investing.com - Investing.com Nigeria

Oct 31, 2024

Oct 30, 2024

Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation By Investing.com - Investing.com South Africa

Oct 30, 2024